Navigating an Ocean of Drug Development & Manufacturing Outsourcing with PhoenixMD

img-event-outsourced-pharma.png

August 22-23 2018 - Outsourced Pharma- San Diego California

Case Study: Inside A (Small) Drug Sponsor - (Big) CDMO Relationship

Dr. Sandra Dunn, founder and CEO of Phoenix Molecular Designs, and members of her senior leadership team, presented a detailed case study and insight into her virtual biotech’s working relationship with CDMO WuXi (San Diego operations), and toxicology service provider Paracelsus, Inc.

“As breast cancer is the #1 cause of death in women world-wide it is a global problem that requires a global solution.  This is why our strategy is to outsource several aspects of our drug development so that we have the opportunity to work with the best and brightest, leveraging years of deep industry experience to catalyze our path to commercialization.Each day women are dying of this terrible disease and working with a highly efficient outsourced team shortens our development time so that we are able to get new medicine to patients sooner” - Dr. Sandra Dunn, CEO and ~30 year veteran breast cancer researcher.

 
 From Left to right: Erik flahive, Grace furman, Gerrit los, wenjie Li, youchu wang and sandra dunn

From Left to right: Erik flahive, Grace furman, Gerrit los, wenjie Li, youchu wang and sandra dunn